Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma

Journal of Experimental Pharmacology - New Zealand
doi 10.2147/jep.s26894
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Rationale for Regenerative Treatment in Neonatology

Klinische Padiatrie
MedicineChild HealthPediatricsPerinatology
2012English

Intravenous Ascorbic Acid Protocol for Cancer Patients: Scientific Rationale, Pharmacology, and Clinical Experience

Functional Foods in Health and Disease
2013English

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

Rationale for Targeting VEGF, FGF, and PDGF for the Treatment of NSCLC

OncoTargets and Therapy
OncologyPharmacology
2011English

Rationale for Bone Marrow Transplantation in the Treatment of Autoimmune Diseases.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Rationale and Options for Combination Therapy in the Treatment of Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Imatinib Is Partially Effective for the Treatment of Pulmonary Capillary Hemangiomatosis

Internal Medicine
Internal MedicineMedicine
2014English

Carotenoids: Biochemistry, Pharmacology and Treatment

British Journal of Pharmacology
Pharmacology
2016English

Rationale for Combination Therapy of Chronic Myelogenous Leukaemia With Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning

British Journal of Cancer
Cancer ResearchOncology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy